Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Specific Activation of T Cells by an ACE2-Based CAR-Like Receptor upon Recognition of SARS-CoV-2 Spike Protein

  • González García, Pablo
  • Muñoz Miranda, Juan Pedro
  • Fernández Cisnal, R.
  • Olvera Collantes, Lucía
  • Moares Fernández, Noelia del Carmen
  • Gabucio López, Antonio
  • Fernández Ponce, Cecilia Matilde
  • García Cózar, Francisco José
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative agent of the Coronavirus Disease 2019 (COVID-19) pandemic, which is still a health issue worldwide mostly due to a high rate of contagiousness conferred by the high-affinity binding between cell viral receptors, Angiotensin-Converting Enzyme 2 (ACE2) and SARS-CoV-2 Spike protein. Therapies have been developed that rely on the use of antibodies or the induction of their production (vaccination), but despite vaccination being still largely protective, the efficacy of antibody-based therapies wanes with the advent of new viral variants. Chimeric Antigen Receptor (CAR) therapy has shown promise for tumors and has also been proposed for COVID-19 treatment, but as recognition of CARs still relies on antibody-derived sequences, they will still be hampered by the high evasion capacity of the virus. In this manuscript, we show the results from CAR-like constructs with a recognition domain based on the ACE2 viral receptor, whose ability to bind the virus will not wane, as Spike/ACE2 interaction is pivotal for viral entry. Moreover, we have developed a CAR construct based on an affinity-optimized ACE2 and showed that both wild-type and affinity-optimized ACE2 CARs drive activation of a T cell line in response to SARS-CoV-2 Spike protein expressed on a pulmonary cell line. Our work sets the stage for the development of CAR-like constructs against infectious agents that would not be affected by viral escape mutations and could be developed as soon as the receptor is identified., 2020 Emergency Call for Research Projects about the SARSCoV- 2 virus and the COVID-19 disease of the Institute of Health ‘Carlos III’, Ministerio de Ciencia e Innovación, Spain, grant number COV20/00173; PAIDI 2020 Consejería de Universidades, Investigación y Tecnología, grant number P20-01293; Consejería de Salud y Familias, Junta de Andalucia, Spain, grant number PECART-0096-2020.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Hyperspectral image processing for the identification and quantification of lentiviral particles in fluid samples

  • Gómez‑González, Emilio
  • Fernández‑Muñoz, Beatriz
  • Barriga‑Rivera, Alejandro
  • Navas‑García, José Manuel
  • Fernández‑Lizaranzu, Isabel
  • Munoz‑González, Francisco Javier
  • Parrilla‑Giráldez, Rubén
  • Requena‑Lancharro, Desiree
  • Guerrero‑Claro, Manuel
  • Gil‑Gamboa, Pedro
  • Rosell‑Valle, Crsitina
  • Gómez‑González, Carmen
  • Mayorga‑Buiza, Maria José
  • Martín‑López, María
  • Muñoz, Olga
  • Gómez Martín, Juan Carlos
  • Relimpio López, María Isabel
  • Aceituno‑Castro, Jesús
  • Perales‑Esteve, Manuel A.
  • Puppo‑Moreno, Antonio
  • García Cózar, Francisco José
  • Olvera Collantes, Lucía
  • de los Santos‑Trigo, Silvia
  • Gómez, Emilia
  • Sánchez Pernaute, Rosario
  • Padillo‑Ruiz, Javier
  • Márquez‑Rivas, Javier
Optical spectroscopic techniques have been commonly used to detect the presence of biofilm-forming pathogens (bacteria and fungi) in the agro-food industry. Recently, near-infrared (NIR) spectroscopy revealed that it is also possible to detect the presence of viruses in animal and vegetal tissues. Here we report a platform based on visible and NIR (VNIR) hyperspectral imaging for non-contact, reagent free detection and quantification of laboratory-engineered viral particles in fluid samples (liquid droplets and dry residue) using both partial least square-discriminant analysis and artificial feed-forward neural networks. The detection was successfully achieved in preparations of phosphate buffered solution and artificial saliva, with an equivalent pixel volume of 4 nL and lowest concentration of 800 TU.mu L-1. This method constitutes an innovative approach that could be potentially used at point of care for rapid mass screening of viral infectious diseases and monitoring of the SARS-CoV- 2 pandemic., This research was funded by grants number COV20-00080 and COV20-00173 of the 2020 Emergency Call for Research Projects about the SARS-CoV-2 virus and the COVID-19 disease of the Institute of Health 'Carlos III', Spanish Ministry of Science and Innovation, and by grant number EQC2019-006240-P of the 2019 Call for Acquisition of Scientific Equipment, FEDER Program, Spanish Ministry of Science and Innovation. This work has been supported by the European Commission through the JRC HUMAINT project. ABR was supported by grant number RTI2018-094465-J funded by the Spanish National Agency of Research. The authors would like to gratefully acknowledge the assistance of the members of the EOD-CBRN Group of the Spanish National Police, whose identities cannot be disclosed, and who are represented here by JMNG. Authors thank continuous support from their institutions.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Optical imaging spectroscopy for rapid, primary screening of SARS-CoV-2: a proof of concept

  • Gómez‑González, Emilio
  • Barriga‑Rivera, Alejandro
  • Fernández‑Muñoz, Beatriz
  • Navas‑García, José Manuel
  • Fernández‑Lizaranzu, Isabel
  • Munoz‑González, Francisco Javier
  • Parrilla‑Giráldez, Rubén
  • Requena‑Lancharro, Desiree
  • Gil‑Gamboa, Pedro
  • Rosell‑Valle, Crsitina
  • Gómez‑González, Carmen
  • Mayorga‑Buiza, Maria José
  • Martín‑López, María
  • Muñoz, Olga
  • Gómez Martín, Juan Carlos
  • Relimpio López, María Isabel
  • Aceituno‑Castro, Jesús
  • Perales‑Esteve, Manuel A.
  • Puppo‑Moreno, Antonio
  • García Cózar, Francisco José
  • Olvera Collantes, Lucía
  • Gómez‑Díaz, Raquel
  • de los Santos‑Trigo, Silvia
  • Huguet‑Carrasco, Montserrat
  • Rey, Manuel
  • Gómez, Emilia
  • Sánchez Pernaute, Rosario
  • Padillo‑Ruiz, Javier
  • Márquez‑Rivas, Javier
Effective testing is essential to control the coronavirus disease 2019 (COVID-19) transmission. Here we report a-proof-of-concept study on hyperspectral image analysis in the visible and near-infrared range for primary screening at the point-of-care of SARS-CoV-2. We apply spectral feature descriptors, partial least square-discriminant analysis, and artificial intelligence to extract information from optical diffuse reflectance measurements from 5 mu L fluid samples at pixel, droplet, and patient levels. We discern preparations of engineered lentiviral particles pseudotyped with the spike protein of the SARS-CoV-2 from those with the G protein of the vesicular stomatitis virus in saline solution and artificial saliva. We report a quantitative analysis of 72 samples of nasopharyngeal exudate in a range of SARS-CoV-2 viral loads, and a descriptive study of another 32 fresh human saliva samples. Sensitivity for classification of exudates was 100% with peak specificity of 87.5% for discernment from PCR-negative but symptomatic cases. Proposed technology is reagent-free, fast, and scalable, and could substantially reduce the number of molecular tests currently required for COVID-19 mass screening strategies even in resource-limited settings., The authors would like to gratefully acknowledge the assistance of the members of the Explosive Ordnance Disposal-Chemical, Biological, Radiological & Nuclear (EOD-CBRN) Group of the Spanish National Police, whose identities cannot be disclosed, and who are represented here by JMNG. The authors also thank Manuel Guerrero-Claro for his technical assistance with the implementation of the neural networks, and the companies CAMBRICO BIOTECH (Sevilla, Spain), CER "Dr. Gregorio Medina Blanco" (Espartinas, Sevilla, Spain) and SAMU (Sevilla, Spain) for their collaboration in the collection of human samples. This research was funded by Grants Number COV20-00080 and COV20-00173 of the 2020 Emergency Call for Research Projects about the SARS-CoV-2 virus and the COVID-19 disease of the Institute of Health 'Carlos III', Spanish Ministry of Science and Innovation, and by Grant Number EQC2019-006240-P funded by MICIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe". ABR was supported by Grant Number RTI2018-094465-J-I00 funded by MICIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe". This work has been supported by the European Commission through the Joint Research Center (JRC) HUMAINT project.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Immunoassay for SARS-CoV-2 Humoral Response Monitorization: A Study of the Antibody Response in COVID-19 Patients with Different Clinical Profiles during the First and Second Waves in Cadiz, Spain

  • Olvera Collantes, Lucía
  • Moares Fernández, Noelia del Carmen
  • Fernández Cisnal, R.
  • Muñoz Miranda, Juan Pedro
  • González García, Pablo
  • Gabucio López, Antonio
  • Freyre Carrillo, Carolina
  • Jordan-Chaves, Juan de Dios
  • Trujillo-Soto, Teresa
  • Rodriguez-Martinez, María P.
  • Martin-Rubio, Maria I.
  • Escuer, Eva
  • Rodríguez Iglesias, Manuel Antonio
  • Fernández Ponce, Cecilia Matilde
  • García Cózar, Francisco José
There is still a long way ahead regarding the COVID-19 pandemic, since emerging waves remain a daunting challenge to the healthcare system. For this reason, the development of new preventive tools and therapeutic strategies to deal with the disease have been necessary, among which serological assays have played a key role in the control of COVID-19 outbreaks and vaccine development. Here, we have developed and evaluated an immunoassay capable of simultaneously detecting multiple IgG antibodies against different SARS-CoV-2 antigens through the use of Bio- PlexTM technology. Additionally, we have analyzed the antibody response in COVID-19 patients with different clinical profiles in Cadiz, Spain. The multiplex immunoassay presented is a high-throughput and robust immune response monitoring tool capable of concurrently detecting anti-S1, anti-NC and anti-RBD IgG antibodies in serum with a very high sensitivity (94.34–97.96%) and specificity (91.84–100%). Therefore, the immunoassay proposed herein may be a useful monitoring tool for individual humoral immunity against SARS-CoV-2, as well as for epidemiological surveillance. In addition, we show the values of antibodies against multiple SARS-CoV-2 antigens and their correlation with the different clinical profiles of unvaccinated COVID-19 patients in Cadiz, Spain, during the first and second waves of the pandemic., Project grant number COV20-00173 of the 2020 Emergency Call for Research Projects about the SARS-CoV-2 virus and the COVID-19 disease of the Institute of Health “Carlos III” from the Spanish Ministry of Science and Innovation; Project grant number PECART-0096-2020, Consejería de Salud y Familias, Junta de Andalucía, Spain.